Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
113.99
+8.73 (8.29%)
May 5, 2026, 2:20 PM EDT - Market open
Veradermics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Veradermics stock have a consensus rating of "Strong Buy" and an average price target of $83.33, which forecasts a -26.90% decrease in the stock price over the next year. The lowest target is $75 and the highest is $90.
Price Target: $83.33 (-26.90%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Veradermics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 |
|---|---|---|
| Strong Buy | 2 | 2 |
| Buy | 2 | 2 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $75 → $90 | Buy | Maintains | $75 → $90 | -21.05% | Apr 22, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2026 |
| Citigroup | Citigroup | Strong Buy Initiates $85 | Strong Buy | Initiates | $85 | -25.43% | Mar 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $75 | Buy | Initiates | $75 | -34.20% | Mar 2, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | -34.20% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
10.60M
EPS This Year
-2.70
from -111.91
EPS Next Year
-2.87
from -2.70
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 43.6M | ||||||
| Avg | n/a | 10.6M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.38 | -2.10 | |
| Avg | -2.70 | -2.87 | |
| Low | -3.12 | -3.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.